iRadimed
IRMD
36 hedge funds and large institutions have $27.7M invested in iRadimed in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 5 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
6% more capital invested
Capital invested by funds: $26.3M → $27.7M (+$1.47M)
1.6% more ownership
Funds ownership: 16.4% → 18% (+1.6%)
3% less funds holding
Funds holding: 37 → 36 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$1.6M |
| 2 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$1.3M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$796K |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$429K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$343K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$906K |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$472K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$323K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$320K |
| 5 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$111K |
IRMD Hedge Fund Activity: Q1 2018 in Review
36 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2018, worth a combined $27.7M — up 5.6% from $26.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IRMD and 4 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 11 added.
The largest buyer was Ranger Investment Management, adding an estimated $1.6M. The largest seller was Granite Investment Partners, cutting an estimated $906K.
- 36 institutional investors held iRadimed (IRMD) as of Q1 2018, down from 37 in Q4 2017.
- Funds reported $27.7M of iRadimed stock for Q1 2018, up 5.6% quarter-over-quarter.
- 4 funds opened new iRadimed positions in Q1 2018 and 5 closed out, a net change of -1 holder.
- The largest iRadimed buyer in Q1 2018 was Ranger Investment Management, an estimated $1.6M added.
- The largest iRadimed seller in Q1 2018 was Granite Investment Partners, an estimated $906K sold.
Based on aggregated 13F filings for Q1 2018.